Search Results - "Angulo, David"

Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections.

Authors: Angulo, David A. Alexander, Barbara Rautemaa-Richardson, Riina et al.

Source: Journal of Fungi. Nov2022, Vol. 8 Issue 11, p1121. 11p.

Box–Jenkins Methodology Application to Improve Crude Oil Production Forecasting: Case Study in a Colombian Field.

Authors: Bello-Angulo, David Mantilla-Duarte, Carlos Montes-Paez, Erik et al.

Source: Arabian Journal for Science & Engineering (Springer Science & Business Media B.V. ). Sep2022, Vol. 47 Issue 9, p11269-11278. 10p.

A zombie apocalypse isn't likely–but a fungal outbreak is.

Authors: Angulo, David (AUTHOR)

Source: Fortune.com. 4/12/2023, pN.PAG-N.PAG. 1p.

Multimodal Model Based on LSTM for Production Forecasting in Oil Wells with Rod Lift System †.

Authors: Bello Angulo, David Esneyder León Guzmán, Elizabeth

Source: Engineering Proceedings; 2024, Vol. 68 Issue 1, p31, 9p

Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306.

Authors: Goje, Oluwatosin Sobel, Ryan Nyirjesy, Paul et al.

Source: Journal of Women's Health (15409996). Feb2023, Vol. 32 Issue 2, p178-186. 9p.

Subjects: Antifungal agents, Drug efficacy, Safety, Oral drug administration, Race, Placebos, Comparative studies, Vulvovaginal candidiasis, Descriptive statistics, Research funding, Body mass index, Evaluation

Dynamics and Forecast in a Simple Model of Sustainable Development for Rural Populations.

Authors: Angulo, David Angulo, Fabiola Olivar, Gerard

Source: Bulletin of Mathematical Biology. Feb2015, Vol. 77 Issue 2, p368-389. 22p.

Experimental study of natural cork and cork agglomerates as a substitute for expanded polystyrene foams under compressive loads.

Authors: Buil, Ramon Miralbes Angulo, David Ranz Ivens, Jan et al.

Source: Wood Science & Technology. Mar2021, Vol. 55 Issue 2, p419-443. 25p.

Subjects: Compression loads, Cork, Polystyrene, Heat treatment, Dynamic loads, Foam

MPI framework for parallel searching in large biological databases

Authors: Battré, Dominic Angulo, David Sigfredo

Source: Journal of Parallel & Distributed Computing. Dec2006, Vol. 66 Issue 12, p1503-1511. 9p.

Subjects: Information storage & retrieval systems, Databases, Amino acid sequence, Mass spectrometry

The Cactus Worm: Experiments with Dynamic Resource Discovery and Allocation in a Grid Environment.

Authors: Allen, Gabrielle Angulo, David Foster, Ian et al.

Source: International Journal of High Performance Computing Applications. Nov2001, Vol. 15 Issue 4, p345. 14p.

Subjects: Computer software, Computer networks

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis.

Authors: Nyirjesy, Paul Schwebke, Jane R Angulo, David A et al.

Source: Clinical Infectious Diseases. 6/15/2022, Vol. 74 Issue 12, p2129-2135. 7p.

Clinical Pharmacokinetics and Drug‐Drug Interaction Potential for Coadministered SCY‐078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus.

Authors: Wring, Stephen Murphy, Gail Atiee, George et al.

Source: Clinical Pharmacology in Drug Development. Jan2019, Vol. 8 Issue 1, p60-69. 10p.

Food and Drug Administration Public Workshop Summary—Development Considerations of Antifungal Drugs to Address Unmet Medical Need.

Authors: Yasinskaya, Yuliya Bala, Shukal Waack, Ursula et al.

Source: Clinical Infectious Diseases. Aug2023, Vol. 77 Issue 3, p380-387. 8p.

Oral Ibrexafungerp Outcomes in Subjects With Refractory Vulvovaginal Candidiasis From an Open-Label Study (FURI) [A122].

Authors: Goje, Oluwatosin King, Thomas Angulo, David et al.

Source: Obstetrics & Gynecology. 2022 Supplement, Vol. 139, p36S-36S. 1p.

FDA Public Workshop Summary—Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs.

Authors: O'Shaughnessy, Elizabeth Yasinskaya, Yuliya Dixon, Cheryl et al.

Source: Clinical Infectious Diseases. Jun2022, Vol. 74 Issue 11, p2061-2066. 6p.

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303).

Authors: Schwebke, Jane R Sobel, Ryan Gersten, Janet K et al.

Source: Clinical Infectious Diseases. Jun2022, Vol. 74 Issue 11, p1979-1985. 7p.

Development of a new car C-pillar made of sandwich structures.

Authors: Valladares, David Castejon, Luis Cuartero, Jesus et al.

Source: Journal of Sandwich Structures & Materials. Sep2021, Vol. 23 Issue 6, p2586-2613. 28p.

MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.

Authors: Spec, Andrej Pullman, John Thompson, George R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Oct2019, Vol. 74 Issue 10, p3056-3062. 7p.

Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions

Authors: Wring, Stephen Murphy, Gail Atiee, George et al.

Source: Journal of Clinical Pharmacology. Oct2018, Vol. 58 Issue 10, p1305-1313. 9p.

672. Activity of Ibrexafungerp (Formerly SCY-078) Against Candida auris: In vitro, In Vivo, and Clinical Case Studies of Candidemia.

Authors: Barat, Stephen Borroto-Esoda, Katyna Ghannoum, Mahmoud et al.

Source: Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS307-S307. 1p.

Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome.

Authors: Krishna, Gopal AbuTarif, Malaz Fengjuan Xuan et al.

Source: Pharmacotherapy. Oct2008, Vol. 28 Issue 10, p1223-1232. 10p. 3 Charts, 3 Graphs.